Reaction

Respiratory Syncytial Virus Bronchiolitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 777 reports · 2 co-occurring drugs

As of the last recalculation, Respiratory Syncytial Virus Bronchiolitis appears in 777 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 819.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Palivizumab	293	819.6	835.6
Vigabatrin	12	22.4	22.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.